Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disodium compretine phosphate with paclitaxel and carboplatin in advanced head and neck solid tumors
CTR20131796Phase 2Active
- Sponsor
- PKU Healthcare Corp., Ltd.
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosbretabulin in head and neck cancer (HNC), sponsored by PKU Healthcare Corp., Ltd.. Started Feb 2014; status: active.
02
Drugs
fosbretabulin
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on CTR20131796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131796.